Hepatic scavenger receptors (SR) may play a protective role by clearing modified lipoproteins before they target the artery wall. To gain insight into this hypothesized function, transgenic mice expressing hepatic bovine SR (TgSR) were created and studied when fed chow, and during diet-induced hyperlipidemia. SR overexpression resulted in extensive hepatic parenchymal cell uptake of fluorescently labeled acetylated human low density lipoprotein (DiI ac-hLDL) and a twofold increase in '"I-acetylated-LDL clearance. Food intake and cholesterol absorption was indistinguishable between control and TgSR mice. In chow-fed mice, lipoprotein cholesterol was similar in control and TgSR mice. However, on a 3-wk high fat/cholesterol (HFHC) diet, the rise in apoB containing lipoproteins was suppressed in TgSR+/-and TgSR+/+ mice. The rise in HDL was similar in control and TgSR+/-mice, but significantly elevated in the TgSR+/+ mice. Overall, on chow, the ratio of apo-B containing lipoprotein cholesterol to HDL cholesterol was similar for all groups (control = 0.33; TgSR+/-= 0.32; TgSR+/+ = 0.38). However, after 3 wk on the HFHC diet, this ratio was markedly higher in control (2.34±0.21) than in either TgSR+/-(1.00±0.24) or TgSR+/+ (1.00±0.19) mice. In TgSR+/-mice, hepatic cholesteryl esters were reduced by 59%, 7a-hydroxylase mRNA levels were elevated twofold, and a significant increase in fecal bile acid flux was observed after the 3-wk HFHC diet. These results suggest SR may play a protective role in liver by preventing diet-induced increases in apoB containing lipoproteins. (J. Clin. Invest. 1995. 96:260-272
Introduction
The macrophage is thought to play a pivotal role in the pathogenesis of atherosclerosis (1) (2) (3) (4) (5) (6) (7) (8) . Scavenger receptors (SR)' are present on macrophages and mediate binding and internalization of a broad variety of ligands including modified apoB containing lipoproteins . SR activity may also be present on smooth muscle, fibroblasts and endothelial cells under specific circumstances (27) (28) (29) . Unlike the LDL receptor, the SR lacks negative feedback regulation by cholesterol allowing the sustained uptake of modified lipoprotein and transformation of macrophages into foam cells (1) (2) (3) . The macrophage-derived foam cell is characteristic of early lesions in a variety of species including humans; its accelerated formation can be mimicked in a variety of animal models fed cholesterol-enriched diets (30, 31) .
Two forms of bovine SR, type I and type II, have been cloned from bovine lung libraries (32, 33) . These trimeric structurally similar receptors are derived from alternative splicing of a single gene product resulting in SR that contain (type I) or lack (type II) the carboxyl terminal cysteine-rich domain (34) . Although the cysteine-rich domain (i.e., type I, domain VI) is highly conserved between species its functional significance is not known. Mutagenesis studies of Acton et al. (35) suggest the collagenous domain (domain V) present in both type I and H SR contain the sequence necessary for recognition of polyanionic ligands. Structural studies of Penman et al. (36) have suggested that the assembly of SR into trimers involves the noncovalent association of a spacer domain (i.e., domain III) disulfide linked dimer with a monomer. The trimeric SR structure, however, does not appear to be requisite for functional binding since monomers are fully capable of binding ligands (37) . Although overwhelming circumstantial evidence suggests modified LDL exists in vivo (5) , their presence has been viewed with skepticism since these particles have not been isolated from plasma. It is likely their compartmentalized formation in the subendothelium and rapid uptake by resident macrophages prevent any accumulation in plasma. However, in vitro and in vivo, macrophage SR avidly bind, internalize and degrade chemically modified LDL. Although smooth muscle cell and macrophage scavenger receptor expression may play a role in lesion formation, their presence in liver may portend a protective role (6) . Indeed, nonparenchymal cells, including Kupffer and endothelial cells are capable of binding and degradation of acetylated and oxidized LDL (12, (38) (39) (40) . Furthermore, 1 . Abbreviations used in this paper: Ac-hLDL, acetylated human LDL; DiI, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; HFHC, high fat high cholesterol diet; HPLC, high pressure liquid chromatography; SR, scavenger receptors; Tg, transgenic. intravenously infused acetylated LDL accumulates primarily in hepatic sinusoidal and endothelial cells, and to a lesser extent in Kupffer cells (12, 39, [41] [42] [43] [44] . Studies utilizing oxidized LDL have instead primarily demonstrated ligand accumulation in Kupffer, and to a lesser extent in endothelial cells (45) . Acetylated LDL uptake by hepatic parenchyma occurs at a near negligible rate (41) . Overall, these studies suggest that liver nonparenchymal cells have the capacity to remove potentially atherogenic lipoproteins.
To directly determine whether or not hepatic SR have a protective anti-atherosclerotic role, transgenic mice overexpressing hepatic bovine SR type I were created in the genetic background of the FVB mouse crossed to the atherosclerosissusceptible C57BL/6J mouse. Both heterozygous (TgSR + / -) and homozygous (TgSR +/+) mice were created. Uptake of modified lipoproteins was greatly enhanced in the liver of these animals. Furthermore, when fed cholesterol-enriched diets, these mice present with marked reductions in apoB-containing lipoproteins and hepatic cholesteryl esters, and increased hepatic 7a-hydroxylase mRNA levels and total fecal bile acids. These data directly demonstrate a potential in vivo anti-atherosclerotic role of hepatic SR.
Methods
Bovine SR minigene preparation. A partial SR type I cDNA clone was isolated from a bovine lung XgtlO cDNA library (Clontech Laboratories, Inc., Palo Alto, CA) using three oligonucleotides that were selected based on the published sequence (32) . This cDNA fragment, 1.8 kb in length, was subcloned into pGEM 3Zf (-) (Promega Corp., Madison, WI). The missing 0.3 kb of the 5' end of the partial cDNA clone was synthesized by coupled reverse transcriptase and polymerase chain reaction (PCR) (46, 47) using bovine lung mRNA (Clontech Laboratories, Inc.) as a template and the specific 5' (5 '-GGGCGTCCGGAT-TTGGAGATATATCTGCA-3') and 3' (5 '-GCGGATCCGAAGTAT-GGCACGTGGGATGACTTTCC-3') primers. This generated cDNA fragment was then ligated into the pGEM 3Zf (-) plasmid (Promega Corp., Madison, WI) that contained 1.8 kb of bovine SR between BamHI in the vector polylinker site and the SR sequence internal Accil restriction site. The full-length bovine SR cDNA was verified (32) by nucleotide sequencing using the dideoxy-chain termination method (48) . To construct the bovine SR minigene, 3 kb of the mouse transferrin promoter (49) were ligated to the 5' end of the bovine SR cDNA. The mouse transferrin promoter contained an artificially introduced BamHI restriction site (49) at the 3' end which was convenient for ligation to the bovine SR clone. The resulting construct contained 5 bp of the 5' untranslated region of the bovine SR upstream of the ATG start site. Inclusion of this short 5-bp untranslated region in the construct appears to be necessary for efficient translation (i.e., "first AUG rule") (50, 51) . At the 3' end of the promoter-bovine SR construct, 0.65 kb of the human growth hormone gene containing the sequence for the poly-A signal were ligated at an Asp700/SmaI fusion site (Fig. 1) . The total size of the minigene construct was 5.2 kb and was isolated by cutting with EcoRI (5' end) and Nod (3' end), purified with Qiaex (Qiagen Inc., Chatsworth, CA) and utilized for production of transgenic mice.
Production of bovine SR transgenic mice. Fertilized one-cell embryos were isolated from superovulated C57BL/6J x FVB mice (Jackson Laboratories). To create transgenic mice, approximately one thousand male pronuclei of the fertilized embryos were microinjected with the purified 5.2-kb minigene construct described above at a DNA concentration of 3 ng/ml (52, 53) For Northern analysis, samples (10 pig total RNA) were heated at 70°C for 10 min in loading buffer (DEPC water, lx MOPS, 6 .6% formaldehyde, 50% formamide, 5% glycerol, bromphenol blue) and then separated by 6.3% formaldehyde-l% agarose gel electrophoresis. RNA was transferred onto Zetaprobe membranes in lOX SSC buffer and hybridized to the random primed 0.7-kb 32P-bovine SR cDNA probe described above (Fig. 1) 'C, prehybridized, and then hybridized at 620C using formamide conditions with either a 0.3-kb mouse 7a-hydroxylase or mouse actin riboprobe generated using a run off kit (Riboprobe Gemini II Core System, Promega) and 32P-CTP (Amersham). The membranes were subject to three 10-min 2x SSC/0.2% SDS washes, first at 40'C, then at 50(C, and then at 620C (7a-hydroxylase) or 50'C (actin). For 7a-hydroxylase, two additional washes continued at 650C in 0.1 x SSC/0.2% SDS for 10 min and then for 20 min. For actin, one additional wash continued at 50TC in 0.1 X SSC/0.2% SDS for 10 min. Image analysis and quantitation of Northern bands were determined on a Molecular Dynamics 400E Phosphoimager (Molecular Dynamics, Sunnyvale, CA).
Protein quantification. For different portions of these studies, protein was determined with either the BCA protein assay reagent (Pierce, Rockford, IL), by the method of Bradford (55) or Lowry et al. (56) . In all cases bovine serum albumin was used as a standard.
Western blot analysis. Liver membranes were isolated from control and TgSR+/-mice according to the method of Via et al (57) . Briefly, livers were homogenized in 50 mM Tris-HCl, 150 mM NaCl, 1mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and 10 U/ml aprotinin, pH 8.0 (4 ml/gram tissue), and spun at 1,500 g for 10 min at 4°C to remove cellular debris. Supernatants were centrifuged at 100,000 g (40,000 rpm in a Beckman Ti6O rotor) for 1 h at 4°C, and membrane pellets were resuspended in ice-cold 40 mM octyl (3- glucopyranoside in 50 mM Tris-HCl, 150 mM NaCl, 1mM EDTA, 0.5 mM PMSF, and 10 U/ml aprotinin, pH 8.0. Nonreduced membrane proteins were electrophoresed on 7.5% SDS polyacrylamide gels and transferred electrophoretically (100 V for 1.5 h at room temperature) to nitrocellulose membranes. Membranes were blocked with 5% nonfat dried milk (blotto) in 50 mM Tris-HCl, 150 mM NaCl, pH 8.0, and then incubated with rabbit anti-bovine SR IgG (a generous gift of Dr. Robert E. Pitas, The Gladstone Institute, San Francisco, CA). After incubation with goat anti-rabbit IgG conjugated to alkaline phosphatase, the bovine SR-antibody complexes were visualized with an ECL detection system (Amersham).
LDL isolation and modifications. Human LDL (hLDL) was isolated by sequential ultracentrifugation between the density intervals of 1.019-1.050 g/ml (58) . hLDL was acetylated with acetic anhydride (achLDL) (2) and used in fluorescence studies (see below). ac-hLDL was radiolabeled with 125I by the iodine monochloride method of MacFarlane (59) and was used for kinetic studies (See below).
Fluorescence histochemistry. ac-hLDL was labeled with DiI according to the method of Voyta et al. (60) . Control and TgSR+/-mice were tail vein injected with DiI ac-hLDL (320 ,g, 1.6 ,ug/ml).
After 10 min, mice were sacrificed and liver tissue was rinsed in PBS and cut into pieces for embedding in OCT (Baxter) on dry ice. Cryostat sections (3 -5 mm) were placed on polylysine coated slides and analyzed by fluorescence microscopy using a rhodamine filter set.
In vivo clearance of acetylated LDL. The kinetics of '25I-ac-hLDL clearance in five TgSR+ / -and five control mice was determined. Mice were tail vein injected with 125I-ac-hLDL (1.6 mg protein, 0.2 ml). Orbitalsinus blood samples (10 il) were collected periodically up to eight min in heparinized microcapillary tubes. Radioactivity data are expressed as percent of the first 20 s time point. To control for non-SR mediated '251I-ac-hLDL clearance, three TgSR+/-and three control mice were co-injected with 0.1 ml of '251-ac-hLDL preparation plus 0.1 ml Fucoidan (10 mg/ml) (1) .
Food consumption studies. Five TgSR+/-and five control mice were maintained on a high fat high cholesterol (HFHC) diet (Diet D12336; Research Diets, Inc., New Brunswick, NJ) for 3 wk in individual metabolic cages. The HFHC diet was similar to the atherogenic diet used by Paigen et al. (61) and contained 1.25% cholesterol, 16% fat (5% soy bean oil, 7.5% cocoa butter, and 3.5% coconut oil), and 0.5% cholic acid. The selected animals had an average body weight of 22-25 g and were 2 mo old. Each group consisted of three males and two females. The weekly amounts of diet consumed by each animal was calculated at day 7, 14 and 21. Feeding study. Five TgSR+/-, four TgSR+/+, and five control mice maintained on chow were fasted for 7-8 h before obtaining 0.3 ml blood from the tail while under Metofane (Pro-Vet) anesthesia. Mice were then put on the HFHC diet for 3 wk. Mice were bleed weekly after a 7-8 h fast. Lipoprotein and lipid analysis. Lipoprotein total cholesterol distribution in 10 u1 plasma samples was determined continuously on-line in the post-column eluant following Superose 6 (Pharmacia Biotech Inc., Piscataway, NJ) high performance gel-filtration chromatography essentially as described (62, 63) except that we used a Rainin HPLC and Dynamax Compare software (Rainin Instrument Co., Inc., Woburn, MA) for instrumentation and data reduction, respectively. Total plasma triglycerides were determined with a commerically available kit (Triglicinet 2 kit; Sclavo Inc. Wayne, NJ). Total plasma cholesterols were determined according to the method of Allain et al. (64) .
Plasma oxysterol analysis. Plasma from eight fasted (8 h) control and 10 TgSR mice that were fed the high fat high cholesterol diet for 3 wk were used to determine oxysterol content by a slight modification of the gas chromatographic methods of Hodis et al. (65) (66) (67) . Briefly, mouse plasmas (25 ILI) were extracted with 6 ml of chloroform/methanol (2/1: vol/vol) containing 0.01% 2,6-di-tert-butyl-4-methyl-phenol (BHT) and 54 /ig 5-a-cholestane (internal standard) and processed up to the diazomethane derivatization step essentially as described (65) . In lieu of diazomethane derivatization, samples were taken to dryness and dissolved in NN-dimethylformamide (DMF) and derivatized with N-methyl-N-(t-butyldimethylsilyl) trifluroacetamide (MTBSTFA) containing 1% t-butyl-dimethylchlorosilane (BDMCS) (Regis Chemical Co., Morton Grove, IL) at 80'C for 1 h. Samples were passed through Acrodisc 13 CR PTFE 0.45 mM filters (Gelman Sciences, Ann Arbor, MI). Cholesterol, 5-a-cholestane (Alltech Associates, Inc., Deerfield, IL.), and oxysterol standards of 5-cholesten-3f3,7a-diol (7a-hydroxycholesterol), 5-cholesten-3f3,7f3-diol (7,8-hydroxycholesterol), cholestan-Sa,6a-epoxy-3/3-ol (a-epoxide), 3,5-cholestadien-7-one (3,5-diene), cholestan-3/.,5a,6,/-triol (cholestane triol), 5-cholesten-3/3,25-diol (25-hydroxycholesterol), 5-cholesten-3/3-ol-7-one (7-ketocholesterol) (Steraloids, Inc., Wilton, NH) and cholestan-5,6,6-epoxy-3,/-ol (/3-epoxy) (Research Plus, Inc., Bayonne, NJ) were individually derivatized as above. Authentic standards, individually and combined in known proportions, reagent blanks, and mouse samples were separated on a RTX-1 (Restek, Bellefonte, PA) capillary column (30 mm X 0.53 mm, 0.5 um film thickness) and quantitated using flame ionization detection on a Varian 3600 gas-liquid chromatograph. Data were collected and analyzed using Turbochrom Data Acquistion system software (PerkinElmer, Oakbrook, IL). Relative response, to correct for injection or detection discrimination, for each component of interest in the sample was determined using known amounts of cholesterol and oxysterol standards in comparison to that of the 5-a-cholestane internal standard. Run conditions employed were; helium carrier gas at 40 cm/s, injector temperature = 300°C, 10 ,l injections, split ratio = 1 to 3, initial column temperature = 250°C maintained for 4 min, linear temperature rise to 320°C at 5°C/min, with final temperature held for 8 min.
Analysis of hepatic lipids. Major hepatic lipid classes were determined in five TgSR+ / -and four control mice that were on the HFHC diet for 25 d. Livers (0.5 grams) were homogenized in a total volume of 5 ml phosphate buffered saline. Aliquots were removed for protein determination (56) and extraction of liver lipids. Homogenized liver (1.0 ml) was extracted with 6 ml ethyl acetate/acetone (2/1:vol/vol) containing 0.01% butylated hydroxytoluene and a 4-hydroxy-cholesterol (1 mg) internal standard in teflon lined-screw cap 20-ml glass tubes according to the method of Slayback et al. (68) . Samples were vigorously mixed for 10 min and extraction continued overnight. After addition of 2 ml water, and 5 min low speed centrifugation (500 rpm), the upper phase containing both polar and nonpolar lipids was removed and evaporated to dryness under nitrogen. Residual (70) . Briefly, feces were homogenized in three volumes of water. An aliquot of the fecal homogenate (1 gram) was mixed with 7 ml of ethanol and heated to 700C for 30 min. The mixture was then filtered through a pleated filter and washed once with 6 ml of preheated ethanol. A 4-ml aliquot from each sample was dried under nitrogen and then dissolved in 2 ml of 3 M NaOH and heated at 100TC for 2 h. Samples (10 al), 2.4 ml of Tris buffer pH 9, and 0.5 ml of reagent (2 mg resazurin, 100 mg ,3-NAD, 6 
Results
Creation of SR transgenic mice. To create mice with hepatic expression of the bovine SR type I, a SR minigene containing the mouse transferrin promoter was constructed (Fig. 1) . Based on the work of Kozak et al (50, 51) , 5 bp of the untranslated region of the bSR cDNA sequence (49) was incorporated into the construct since inclusion of this element should facilitate the correct initiation and highly efficient translation of the SR. In our experiments this concept was not examined rigorously in that we did not construct nor test a minigene lacking these 5 bp. The SR minigene was injected into hybrid fertilized eggs obtained from a C57BL/6J female crossed to a FVB male. PCR and Southern blotting indicated three potential transgenic mice were created (data not shown). These mice were breed to C57BL/6J; offspring from these crosses indicated that out of the three potential founders, two were chimerics and one had transgene incorporation into the germline. Southern Expression of the bovine SR in transgenic mice. Tissue specific expression of bovine SR mRNA was examined by RT-PCR and Northern blot analysis of total RNA isolated from tissues of TgSR+/-and nontransgenic controls (C57BL/6J x FVB). By RT-PCR a lkb cDNA fragment was amplified in TgSR+/-but not in control mice (Fig. 2) , demonstrating the presence of bovine SR mRNA in the TgSR+/-mouse liver. Bovine SR mRNA was predominantly expressed in liver with a much smaller amount found in kidney. A minute amount of bovine SR expression was also observed in brain (Fig. 2) . We estimate, hepatic mRNA levels of the bovine SR to be approximately 20-30-fold higher than the endogenous mouse SR (data not shown).
Detergent solubilized nonreduced liver membrane preparations from the TgSR+ /-mice revealed the presence of monomeric plus possibly monomeric precursors (up to -80 kD), dimeric (-160 kD), and trimeric (-240 kD) forms of the bovine SR by Western blotting (Fig. 3) .
Hepatic parenchymal and nonparenchymal expression of the bovine scavenger receptor. Histological examination of liver sections following intravenous infusion of fluorescent Dil-acetylated human LDL in control and TgSR+ / -mice indicates the presence of the fluorescence probe in nonparenchymal cells (e.g., sinusoidal cells) (Fig. 4) . However, unlike a control mouse, TgSR+ / -mouse liver parenchymal cells were fluorescent suggesting these cells expressed the transgene (Fig. 4) .
Fractional catabolism of 12" acetylated LDL in scavenger receptor transgenic mice. The fractional catabolism of 125I achLDL was determined in five TgSR+ / -and five nontransgenic littermates. Mice were tail vein injected with the probe and 10 01 sinus orbital bleeds were periodically taken up to eight minutes. The T112 for "2I ac-hLDL clearance in the TgSR+/-was 2.5 times faster (75 s) than in control mice (186 s) (Fig.  5) . In three TgSR+/-and three nontransgenic littermates simultaneously injected with both Fucoidan and 1251 ac-hLDL, the SR mediated clearance of the probe was blocked (Fig. 5 glycerides and total cholesterol from control, TgSR+/-, and TgSR+ / + mice initially on a chow diet then maintained on the HFHC diet for three weeks are shown in Table I . In all mice and under all dietary conditions plasma triglycerides were similar (Table I) . On chow, basal cholesterol levels were similar in control and transgenic mice. When fed the high fat high cholesterol diet, total plasma cholesterol rose in all mice. However, at week three, total plasma cholesterol in the TgSR+/-and TgSR+ / + mice increased to only 59 and 83%, respectively, of that observed in the control mice. High performance gelfiltration chromatographic lipoprotein profile analysis of plasma from these mice (Fig. 6 ) was used to determine the distribution of cholesterol between lipoproteins (Fig. 7) . On the chow diet lipoprotein cholesterol profiles were similar in control and SR transgenic mice; HDL carried the majority of cholesterol under these conditions (Figs. 6 and 7) . When fed the HFHC diet, cholesterol predominantly rose in apoB containing lipoproteins relative to HDL in control mice (Figs. 6 and 7) . In both TgSR+ / -and TgSR+ / + mice, apoB containing lipoproteins, rose to only half the amount observed in the control mice (Figs. 6 and 7). In the TgSR+/-mice, HDL rose more rapidly than the controls, however after 3 wk on the HFHC diet HDL cholesterol levels converged (Fig. 7) . In contrast, in the TgSR +/+ mice fed the HFHC diet, HDL cholesterol continued to rise and the level was significantly greater than control mice levels at three weeks (Figs. 6 and 7). These marked differences in lipoprotein profiles can be appreciated as the ratio of apoB-containing lipoprotein cholesterol to that of HDL cholesterol (Fig.  7) . Thus, in the TgSR+/-and TgSR+/+ mice this ratio rose 2.8-fold with the HFHC diet, while this ratio rose to 6.6-fold in the control mice. Plasma oxysterols. To determine whether products of cholesterol oxidation would differ due to the overexpression of the SR, 10 TgSR, and 8 control mice were maintained on the HFHC diet for 3 wk and plasma from fasted animals were analyzed for oxysterols by gas liquid chromatography. Five of the eight oxysterols monitored were not detectable in the plasma of either transgenic or control mice. Of the detectable plasma oxysterols, the levels were (mg/dl±SEM); 4.52±1.08 and 2.54±0.56 for 3,5-cholestadien-7-one, 2.71±0.33 and 2.46±0.09 for cholestan-5a,6a-epoxy-3f6-ol, and 16.37±2.00 and 21.26+0.95 for 5-cholesten-3,f,25-diol in the transgenic and control mice, respectively. By this analysis, plasma cholesterol (mg/dl±SEM) was 239±18 and 246±23 in the transgenic and control mice, respectively. Neither oxysterol nor cholesterol levels were statistically different between the control and transgenic mice (unpaired t test).
Cholesterol absorption andfood intact studies. Diminished total plasma cholesterol in the transgenic mice could possibly reflect a reduced food intake or an impeded cholesterol absorption. Food intake was therefore recorded over a 3-wk period for five control and five TgSR+ / -on the HFHC diet. Average body weight for each group was 22 grams. Weekly food intake was virtually identical between groups; control mice consumed 23.1, 22.9, 24.3 grams/week, while the TgSR+/-mice consumed 21.9, 27.5, 24.7 grams/week, for the first, second and third week, respectively.
Next, cholesterol absorption was determined in three control and five TgSR+/-mice. Animals were oral gavaged with a 3H-cholesterol/'4C-f3-sitosterol in sunflower oil, placed on the HFHC diet and feces were collected for four days. The 3H/ 4C ratio in the oral dose and in the neutral lipid fraction extracted Overall, these studies suggest the diminished levels of plasma cholesterol observed in the SR transgenic mice were not the result of reduced food intake or cholesterol absorption.
Hepatic lipids. Gross visual examination of control and
TgSR+/-livers from mice maintained on chow diets showed no evidence of fatty accumulations. Livers of control mice fed the HFHC diet showed considerable fat accumulation. In contrast, livers from TgSR+/-mice fed the HFHC diet appeared normal (not shown) or only slightly discolored (shown) (Fig.  8) . To determine whether hepatic lipids would accumulate in the SR transgenic mice, lipid analysis was performed on the four control and five TgSR+/-mice after three weeks on the high fat high cholesterol diet (i.e., from animals studied in Table  I , Figs. 6 and 7) . In the TgSR+/-mice, hepatic cholesteryl esters, triglycerides and non-esterified cholesterol did not accumulate, but were instead significantly reduced by 59, 61, and 36 percent, respectively (Fig. 8) . Hepatic phosphatidylethanolamine and phosphatidylcholine levels were similar (Fig. 8) .
Fecal bile acids. To determine whether there would be an increase flux of bile acids in the SR transgenic mice, total fecal bile acids were determined weekly in five control and five TgSR+ / -mice fed chow one week, and the HFHC diet for 3 wk. On chow, fecal bile acids were similar in control (1.51±0.20 mg/wk) and TgSR+/-(1.37±0.04 mg/wk) mice. On the HFHC diet, fecal bile acids markedly increased 5.4-fold by one week (8.19±0 .95 mg/wk) and remained constant throughout the study (week two, 8.06±1.65 mg/wk; week three, 8.49±0.36 mg/wk). Similarly, the fecal bile acids in TgSR+/-mice fed the HFHC diet increased 5.8-fold in the first week (7.91± 1.54 mg/wk). In contrast, however, fecal bile acids in the subsequent two weeks progressively increased becoming significantly elevated by the third week (week two, 9.23±1.17 mg /wk; week three, 10.83±0.33 mg/wk) (Fig. 9) .
Hepatic 7a-hydroxylase mRNA levels. To determine if messenger RNA levels for 7a-hydroxylase (the rate limiting enzyme for hepatic bile acid synthesis) were elevated to a greater extent in the TgSR+ / -mice, total hepatic RNA was extracted from two control and two TgSR+/-mice maintained on the HFHC diet for three weeks. Northern blot analysis demonstrates 7a-hydroxylase mRNA levels relative to mouse actin mRNA were elevated twofold in the TgSR+/-compared with the control mice (Fig. 10) . (Table I ) and lipoprotein profiles from data shown in Fig. 6 were used for the determinations.
Data points represent the mean±SEM.
dominantly to the liver. Hepatic fluorescent microscopy of the TgSR+/-mice injected with Di-I acetylated-LDL demonstrated SR activity in the sinusoidal endothelial cells, which normally express SR (12, (38) (39) (40) (41) (42) (43) (44) (45) and also in hepatocytes in which SR are normally barely detectable (41) . As has been suggested by the early studies from the laboratory of Brown and Goldstein (6) , SR have been hypothesized to play a protective role in atherogenesis by removing modified lipoproteins. Indeed, apoB containing lipoproteins from rabbits fed high cholesterol diets are more susceptible to Cu2" induced modification than LDL isolated from control rabbits in vitro (71) . Although direct evidence for the existence of circulating modified lipoproteins is sparse, studies of Palinski et al (72, 73) have indirectly suggested the presence of in vivo oxidative modification of LDL in LDL-receptor deficient rabbits and apoE-deficient mice (74). These studies (72, 73) demonstrate the presence of high titers of autoantibodies to malondialdehyde-lysine, an epitope that presents on "modified" lipoproteins. The studies of Hodis et al (65) (66) (67) we postulate that decreased lesion formation will be observed in mice that overexpress the hepatic SR. To test this hypothesis we have begun to explore a variety of different models. Mice have been created that overexpress bovine SR in bone marrow and peritoneal macrophages. Studies to determine if this condition exasperates atherosclerosis are ongoing. Additional studies of crosses between TgSR to apoE deficient mice are also ongoing to determine whether hepatic SR overexpression can rescue the apoE deficient mice from production of autoantibodies to modified lipoproteins (73) , overproduction of vascular cell adhesion molecule-i (84) , and atherosclerosis development (74, [85] [86] [87] . Similarly, we are also assessing whether the TgSR mice can rescue LDL receptor deficient mice from atherosclerosis development (88, 89) . The outcome of these rescue studies will help focus the potential use of somatic gene therapy to direct hepatic specific expression of the SR. However, the technology for delivery and long term somatic expression of gene products is still in its infancy. 
